Goldman Sachs’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.81K | Sell |
14,376
-25
| -0.2% | -$17 | ﹤0.01% | 5068 |
|
|
2025
Q1 | $13.1K | Sell |
14,401
-20,124
| -58% | -$18.3K | ﹤0.01% | 4995 |
|
|
2024
Q4 | $37.6K | Buy |
34,525
+15,962
| +86% | +$17.4K | ﹤0.01% | 4865 |
|
|
2024
Q3 | $14.1K | Sell |
18,563
-247,810
| -93% | -$188K | ﹤0.01% | 4720 |
|
|
2024
Q2 | $330K | Buy |
266,373
+220,735
| +484% | +$274K | ﹤0.01% | 4161 |
|
|
2024
Q1 | $86.3K | Sell |
45,638
-12,686
| -22% | -$24K | ﹤0.01% | 4479 |
|
|
2023
Q4 | $154K | Buy |
58,324
+39,211
| +205% | +$104K | ﹤0.01% | 4394 |
|
|
2023
Q3 | $44K | Buy |
19,113
+1,506
| +9% | +$3.46K | ﹤0.01% | 4495 |
|
|
2023
Q2 | $64.3K | Buy |
17,607
+3,683
| +26% | +$13.4K | ﹤0.01% | 4641 |
|
|
2023
Q1 | $49.7K | Sell |
13,924
-163
| -1% | -$582 | ﹤0.01% | 4768 |
|
|
2022
Q4 | $40.1K | Buy |
14,087
+110
| +0.8% | +$314 | ﹤0.01% | 4814 |
|
|
2022
Q3 | $31K | Sell |
13,977
-136,228
| -91% | -$302K | ﹤0.01% | 5089 |
|
|
2022
Q2 | $374K | Sell |
150,205
-352
| -0.2% | -$876 | ﹤0.01% | 4564 |
|
|
2022
Q1 | $735K | Sell |
150,557
-1,866
| -1% | -$9.11K | ﹤0.01% | 4331 |
|
|
2021
Q4 | $1.72M | Sell |
152,423
-82,002
| -35% | -$927K | ﹤0.01% | 3602 |
|
|
2021
Q3 | $3.42M | Sell |
234,425
-160,225
| -41% | -$2.33M | ﹤0.01% | 3066 |
|
|
2021
Q2 | $4.6M | Sell |
394,650
-207,444
| -34% | -$2.42M | ﹤0.01% | 2844 |
|
|
2021
Q1 | $7.35M | Buy |
602,094
+88,724
| +17% | +$1.08M | ﹤0.01% | 2409 |
|
|
2020
Q4 | $6.42M | Buy |
513,370
+175,636
| +52% | +$2.2M | ﹤0.01% | 2333 |
|
|
2020
Q3 | $5.08M | Buy |
337,734
+7,176
| +2% | +$108K | ﹤0.01% | 2370 |
|
|
2020
Q2 | $8.1M | Buy |
330,558
+174,137
| +111% | +$4.27M | ﹤0.01% | 2060 |
|
|
2020
Q1 | $2.22M | Buy |
+156,421
| New | +$2.22M | ﹤0.01% | 2699 |
|
|
2018
Q3 | – | Sell |
-12,392
| Closed | -$147K | – | 4125 |
|
|
2018
Q2 | $147K | Buy |
+12,392
| New | +$147K | ﹤0.01% | 3945 |
|